These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 231193)

  • 1. Quantitation and characterization of human platelet alpha-adrenergic receptors using [3H]phentolamine.
    Steer ML; Khorana J; Galgoci B
    Mol Pharmacol; 1979 Nov; 16(3):719-28. PubMed ID: 231193
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for high and low affinity alpha 2-receptors. Comparison of [3H]norepinephrine and [3H]phentolamine binding to human platelet membranes.
    Lynch CJ; Steer ML
    J Biol Chem; 1981 Apr; 256(7):3298-303. PubMed ID: 6259160
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular pharmacology of alpha adrenergic receptors: utilization of [3H]dihydroergocryptine binding in the study of pharmacological receptor alterations.
    Williams LT; Lefkowitz RJ
    Mol Pharmacol; 1977 Mar; 13(2):304-13. PubMed ID: 192992
    [No Abstract]   [Full Text] [Related]  

  • 4. Agonist-specific effects of guanine nucleotides on alpha-adrenergic receptors in human platelets.
    Tsai BS; Lefkowitz RJ
    Mol Pharmacol; 1979 Jul; 16(1):61-8. PubMed ID: 39249
    [No Abstract]   [Full Text] [Related]  

  • 5. Solubilization of human platelet alpha-adrenergic receptors: evidence for agonist-promoted receptor-effector association.
    Limbird LE; MacMillan ST; Smith SK
    Adv Cyclic Nucleotide Res; 1981; 14():189-98. PubMed ID: 6116384
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of alpha-adrenergic receptors in human platelets using [3H]clonidine.
    Shattil SJ; McDonough M; Turnbull J; Insel PA
    Mol Pharmacol; 1981 Jan; 19(1):179-83. PubMed ID: 6259509
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium ion modulates agonist and antagonist interactions with the human platelet alpha 2-adrenergic receptor in membrane and solubilized preparations.
    Limbird LE; Speck JL; Smith SK
    Mol Pharmacol; 1982 May; 21(3):609-17. PubMed ID: 6125876
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple alpha 2-noradrenergic receptor sites in rat brain: selective regulation of high-affinity [3H]clonidine binding by guanine nucleotides and divalent cations.
    Rouot BM; U'Prichard DC; Snyder SH
    J Neurochem; 1980 Feb; 34(2):374-84. PubMed ID: 6251166
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions of divalent cations and guanine nucleotides at alpha 2-noradrenergic receptor binding sites in bovine brain mechanisms.
    U'Prichard DC; Snyder SH
    J Neurochem; 1980 Feb; 34(2):385-94. PubMed ID: 6251167
    [No Abstract]   [Full Text] [Related]  

  • 10. Agonist-specific effects of monovalent and divalent cations on adenylate cyclase-coupled alpha adrenergic receptors in rabbit platelets.
    Tsai BS; Lefkowitz RJ
    Mol Pharmacol; 1978 Jul; 14(4):540-8. PubMed ID: 210368
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular pharmacology of adenylate cyclase-coupled alpha- and beta-adrenergic receptors.
    Lefkowitz RJ; De Lean A; Hoffman BB; Stadel JM; Kent R; Michel T; Limbird L
    Adv Cyclic Nucleotide Res; 1981; 14():145-61. PubMed ID: 6269377
    [No Abstract]   [Full Text] [Related]  

  • 12. Agonist regulation of the human platelet alpha-adrenergic receptor.
    Cooper B; Handin RI; Young LH; Alexander RW
    Nature; 1978 Aug; 274(5672):703-6. PubMed ID: 209342
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of monovalent and divalent cations on the alpha-adrenoceptor of intact human platelets.
    Elliott JM; Grahame-Smith DG
    Br J Pharmacol; 1982 Oct; 77(2):277-83. PubMed ID: 6291686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine.
    Motulsky HJ; Shattil SJ; Insel PA
    Biochem Biophys Res Commun; 1980 Dec; 97(4):1562-70. PubMed ID: 6260094
    [No Abstract]   [Full Text] [Related]  

  • 15. Apparent "down-regulation" of human platelet alpha 2-adrenergic receptors is due to retained agonist.
    Karliner JS; Motulsky HJ; Insel PA
    Mol Pharmacol; 1982 Jan; 21(1):36-43. PubMed ID: 6127620
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of new haloperidol analogues and characterization of their interactions with alpha-adrenoceptors in rat parotid slices and human platelet membranes.
    Atlas D; Friedman Z; Litvin Y; Steer ML
    Br J Pharmacol; 1982 Jan; 75(1):213-7. PubMed ID: 6280800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine.
    Corby DG; O'Barr TP
    Dev Pharmacol Ther; 1981; 2(4):215-25. PubMed ID: 6266790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
    Lanier SM; Hess HJ; Grodski A; Graham RM; Homcy CJ
    Mol Pharmacol; 1986 Mar; 29(3):219-27. PubMed ID: 3005829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo down-regulation of human platelet alpha 2-adrenoceptors by clonidine.
    Brodde OE; Anlauf M; Graben N; Bock KD
    Eur J Clin Pharmacol; 1982; 23(5):403-9. PubMed ID: 6295774
    [No Abstract]   [Full Text] [Related]  

  • 20. Yohimbine and clonidine recognize different states of adrenergic receptors on human platelets: reconsideration of studies on platelet alpha-2 receptors in depressive illness.
    Piletz JE; Halaris A
    Psychopharmacol Bull; 1985; 21(3):573-8. PubMed ID: 2994160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.